SE9900398L - Ny användning inom transplantationskirurgi - Google Patents

Ny användning inom transplantationskirurgi

Info

Publication number
SE9900398L
SE9900398L SE9900398A SE9900398A SE9900398L SE 9900398 L SE9900398 L SE 9900398L SE 9900398 A SE9900398 A SE 9900398A SE 9900398 A SE9900398 A SE 9900398A SE 9900398 L SE9900398 L SE 9900398L
Authority
SE
Sweden
Prior art keywords
transplantation
new use
transplant surgery
present
islets
Prior art date
Application number
SE9900398A
Other languages
Unknown language ( )
English (en)
Other versions
SE523817C2 (sv
SE9900398D0 (sv
Inventor
Olle Korsgren
William Bennet
Bo Nilsson
Rolf Larsson
Original Assignee
Corline Systems Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corline Systems Ab filed Critical Corline Systems Ab
Priority to SE9900398A priority Critical patent/SE523817C2/sv
Publication of SE9900398D0 publication Critical patent/SE9900398D0/sv
Priority to PCT/SE2000/000223 priority patent/WO2000045837A1/en
Priority to AU28399/00A priority patent/AU769063B2/en
Priority to CA2361949A priority patent/CA2361949C/en
Priority to JP2000596956A priority patent/JP2003501346A/ja
Priority to US09/890,936 priority patent/US7981873B1/en
Priority to EP00906843A priority patent/EP1171156B1/en
Priority to AT00906843T priority patent/ATE348149T1/de
Priority to DE60032346T priority patent/DE60032346T2/de
Publication of SE9900398L publication Critical patent/SE9900398L/sv
Publication of SE523817C2 publication Critical patent/SE523817C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9900398A 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler SE523817C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler
DE60032346T DE60032346T2 (de) 1999-02-05 2000-02-04 Neue Verwendung in der Transplantationsschirugie
JP2000596956A JP2003501346A (ja) 1999-02-05 2000-02-04 移植手術における新規な使用
AU28399/00A AU769063B2 (en) 1999-02-05 2000-02-04 Novel use within transplantation surgery
CA2361949A CA2361949C (en) 1999-02-05 2000-02-04 Heparin, or heparin conjugate, islets of langerhans
PCT/SE2000/000223 WO2000045837A1 (en) 1999-02-05 2000-02-04 Novel use within transplantation surgery
US09/890,936 US7981873B1 (en) 1999-02-05 2000-02-04 Use within transplantation surgery
EP00906843A EP1171156B1 (en) 1999-02-05 2000-02-04 Isolierte inslen, die insulin-produzierende zellen enthalten, beschichtete mit heparin
AT00906843T ATE348149T1 (de) 1999-02-05 2000-02-04 Isolated islets, comprising insulin producing cells, coated with heparin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler

Publications (3)

Publication Number Publication Date
SE9900398D0 SE9900398D0 (sv) 1999-02-05
SE9900398L true SE9900398L (sv) 2000-08-06
SE523817C2 SE523817C2 (sv) 2004-05-18

Family

ID=20414376

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler

Country Status (9)

Country Link
US (1) US7981873B1 (sv)
EP (1) EP1171156B1 (sv)
JP (1) JP2003501346A (sv)
AT (1) ATE348149T1 (sv)
AU (1) AU769063B2 (sv)
CA (1) CA2361949C (sv)
DE (1) DE60032346T2 (sv)
SE (1) SE523817C2 (sv)
WO (1) WO2000045837A1 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0200198D0 (sv) 2002-01-23 2002-01-23 Astrazeneca Ab New use
DK1605965T3 (da) * 2003-03-26 2013-04-15 Evotec Internat Gmbh Anvendelse af saposin-beslægtede proteiner til forebyggelse og behandling af obesitet, diabetes og/eller metabolisk syndrom
CA2612621C (en) * 2005-07-01 2014-11-18 Corline Systems Ab Heparin coating of biological tissue
SE530716C2 (sv) 2006-10-06 2008-08-19 Corline Systems Ab Molekylärt aggregat på ett substrat
CN102917711A (zh) * 2010-03-12 2013-02-06 澳大利亚国立大学 硫酸乙酰肝素替代疗法
ES2926906T3 (es) 2011-12-22 2022-10-31 Corline Biomedical Ab Medios y método para tratar vasos sanguíneos
WO2017149391A1 (en) * 2016-03-02 2017-09-08 Laboratoire Francais Du Fractionnement Et Des Biotechnologies The use of antithrombin for coating organs during transplantation
WO2024205480A1 (en) 2023-03-30 2024-10-03 Corline Biomedical Ab A method for providing an improved heparin functionalized surface
CN120957766A (zh) 2023-03-30 2025-11-14 科林生物医学公司 肝素官能化表面及其制备和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135916A (en) 1989-06-12 1992-08-04 Oklahoma Medical Research Foundation Inhibition of complement mediated inflammatory response
CN1122719C (zh) * 1989-10-12 2003-10-01 艾姆特兰有限公司 经修饰的生物材料
US5925331A (en) 1992-05-21 1999-07-20 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
SE470006B (sv) 1991-09-26 1993-10-25 Corline Systems Ab Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
WO1993009176A2 (en) * 1991-10-29 1993-05-13 Clover Consolidated, Limited Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
AU721737B2 (en) 1995-09-27 2000-07-13 Bristol-Myers Squibb Company Method of inhibiting immune system destruction of transplanted viable cells
DE19623440A1 (de) * 1996-06-12 1997-12-18 Wagner Karl Heinz Dr Med Immobilisiertes organisches Material mit definiertem Wirkstoff-Release
ES2513043T3 (es) 1997-03-26 2014-10-24 Imperial Innovations Limited Proteína de fusión anticoagulante anclada a membrana de la célula

Also Published As

Publication number Publication date
AU2839900A (en) 2000-08-25
SE523817C2 (sv) 2004-05-18
DE60032346D1 (en) 2007-01-25
JP2003501346A (ja) 2003-01-14
WO2000045837A1 (en) 2000-08-10
CA2361949C (en) 2010-08-03
US7981873B1 (en) 2011-07-19
ATE348149T1 (de) 2007-01-15
AU769063B2 (en) 2004-01-15
DE60032346T2 (de) 2007-07-19
EP1171156B1 (en) 2006-12-13
CA2361949A1 (en) 2000-08-10
EP1171156A1 (en) 2002-01-16
SE9900398D0 (sv) 1999-02-05

Similar Documents

Publication Publication Date Title
TW200621257A (en) Pyrimidine derivative fused with nonaromatic ring
WO2009023718A3 (en) Novel activators of glucokinase
CN105979975A (zh) 医疗敷料
SE9900398L (sv) Ny användning inom transplantationskirurgi
EP1803721A4 (en) INNOVATIVE GLUCITOL DERIVATIVE, PRECURSOR OF THE MEDICINAL PRODUCT AND SALT THEREOF, AND A THERAPEUTIC AGENT FOR DIABETES CONTAINING THE SAME
Liang et al. Lipid rescue of massive verapamil overdose: a case report
CA3168881C (en) Slow intraventricular delivery
RU2009110273A (ru) Способ уменьшения повреждения нервных клеток
CN1387439A (zh) 糖尿肾病和微蛋白尿的治疗方法
WO2005103687A3 (en) System and method for providing optimal concentrations for medication infusions
NO20052505L (no) Ny bruk av dextran-sulfat
Xie et al. Biomaterial-mediated strategies for accurate and convenient diagnosis, and effective treatment of diabetes: advantages, current progress and future perspectives
CA2593171A1 (en) Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases
TR200200250T2 (tr) Glukoz alma agonistleri olarak yeni naftilsülfonik asitler, ilgili bileşikler
EA199900510A1 (ru) Инъекционное лекарственное средство "цитофлавин", обладающее цитопротекторным действием
Wallenborn et al. Intensive care in a patient with toxic epidermal necrolysis
CO5611170A2 (es) Uso de un inhibidor antagonista contra el factor tisular
KR101823205B1 (ko) 약물을 봉입한 이식 치료용 세포 클러스터 및 이의 제조방법
CN206434601U (zh) 一种新型辣椒碱水凝胶贴剂
CN102068441A (zh) 一种含有替米沙坦和格列美脲的复方制剂
CN112209834A (zh) 一种有机亚硝酸根供体及其制备方法与医药用途
CN101474178A (zh) 盐酸戊乙奎醚在制备治疗心源性休克疾病药物中的应用
CN2870885Y (zh) 长效降血压埋植棒
WO2018219033A1 (zh) 一种2型糖尿病的多药联用康复冲剂及其应用
Feldman-Billard et al. Type 1 diabetes with no diabetic complications, 62 years later

Legal Events

Date Code Title Description
NUG Patent has lapsed